☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
pfizer
Pfizer and BioNTech Report the CHMP’s Positive Opinion of Comirnaty JN.1 Vaccine for COVID-19
June 28, 2024
Pfizer Reports the P-III Trial Data of Fordadistrogene Movaparvovec for Duchenne Muscular Dystrophy
June 13, 2024
Pfizer Reports the P-III (ECHELON-3) Trial Results of Adcetris for Treating R/R Diffuse Large B-cell Lymphoma (DLBCL)
June 3, 2024
Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)
May 1, 2024
Pfizer’s BEQVEZ (fidanacogene elaparvovec-dzkt) Receives US FDA Approval for Adults with Hemophilia B
April 26, 2024
Pfizer Reports Results from P-III Trial of Abrysvo for Increased Risk for RSV Disease
April 9, 2024
Load more...
Back to Home